不确定性甲状腺结节的癌症风险分层:一种细胞学方法
该研究回顾性分析了518个不确定性细胞学(Bethesda-III或IV)甲状腺结节,将其亚分为核异型性、结构异型性、嗜酸细胞特征或其他类型异型性四组,在323个有组织学确认的结节中计算恶性患病率和恶性比值比。结果显示核异型性组恶性患病率47%,结构异型性组12%,嗜酸细胞特征组24%,其他类型异型性组25%,细胞学亚分类可有效分层恶性风险并改善细胞学-组织学相关性。
要点
- 不确定性细胞学结节中,核异型性组恶性患病率47%,结构异型性组12%,嗜酸细胞特征组24%。
- 细胞学亚分类与不同的组织学诊断谱相关,改善了细胞学-组织学相关性(P < 0.001)。
核心结论
- 细胞学亚分类可有效分层不确定性细胞学甲状腺结节的恶性风险,并改善细胞学-组织学相关性。
研究设计与样本
- 回顾性研究,连续纳入2008年10月至2015年9月在本学术癌症中心评估的518个不确定性细胞学(Bethesda-III或IV)甲状腺结节,细胞学标本对组织学结局设盲,亚分为四组,在323个有组织学确认的结节中计算恶性患病率和恶性比值比。
主要发现
- 总体恶性患病率为26%(Bethesda-III为20%,Bethesda-IV为29%;P = 0.07)。
- 核异型性组恶性患病率47%,结构异型性组12%,嗜酸细胞特征组24%,其他类型异型性组25%。
- Bethesda-III和IV标本独立分析时结果相似;细胞学亚分类与不同的组织学诊断谱相关(P < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management recommendations for thyroid nodules rely primarily on the cytological diagnosis. However, 25% of biopsies render an indeterminate cytology for which management decision is more challenging due to heterogeneity of the specimens. This study aimed to stratify the cancer risk through subcategorization of indeterminate cytology. METHODS: The indeterminate cytological specimens (Bethesda-III or IV) of 518 thyroid nodules consecutively evaluated at our academic cancer center between October 2008 and September 2015, blinded to the histological outcome, were retrospectively reviewed. Cytological specimens were subclassified into four groups: aspirates exhibiting nuclear atypia (n = 158; 31%); architectural atypia (n = 222; 43%); oncocytic features (n = 120; 23%); or other types of atypia (n = 18; 3%). The prevalence of malignancy and odds ratio for malignancy were calculated in 323 nodules with histological confirmation. RESULTS: The prevalence of malignancy was 26% overall (20% in Bethesda-III and 29% in Bethesda-IV; p = 0.07), and 47%, 12%, 24%, and 25% for aspirates with nuclear atypia, architectural atypia, oncocytic features, or other types of atypia, respectively. The OR of nuclear atypia over architectural atypia was 6.4 (3.4-12.2; p < 0.001), and 2.7 over oncocytic features (1.4-5.1; p = 0.01), whereas the OR of architectural atypia over oncocytic features was 0.4 (0.2-0.9; p = 0.03). Results were similar for Bethesda-III and IV aspirates when analyzed independently. Furthermore, cytological subcategories improved cytology-histology correlation, as they were associated with distinct profiles of histological diagnoses (p < 0.001). CONCLUSIONS: Cytological subcategories can effectively stratify the risk of malignancy of thyroid nodules with indeterminate cytology and improve cytology-histology correlation.
引用
- Valderrabano P, Khazai L, Thompson ZJ, et al. Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological Approach. Thyroid. 2017. PMID: 28806881. doi:10.1089/thy.2017.0221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。